Observational studyHuman vaccines & immunotherapeutics2025
Safety monitoring of GSK's quadrivalent seasonal influenza vaccine in European countries during the 2023/24 flu season: A multicenter, non-interventional study.
Ignacio Salamanca de la Cueva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.